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Background
Systemic events in acute HIV infection (AHI) are associ-
ated with disease severity and progression to AIDS. Timely
identification of AHI patients has posed a significant chal-
lenge to identifying the underlying mechanisms driving
these events. The aim of this study is to elucidate these
pathways by characterizing the genome-wide transcrip-
tional signature expressed by whole blood during early
AHI.
Methods
Longitudinal whole blood samples from ART treated and
untreated patients from both the United States (n = 16)
and Africa (n = 16) were collected at study enrollment and
weeks 1, 2, 4, 12, and 24. AHI and non-infected controls
were analyzed using Illumina HT-12 microarrays. Both
gene and module level analysis were conducted to identify
biologic pathways active in AHI.
Results
Nineteen annotated and 24 undefined transcriptional
modules constitute a robust transcriptional signature that
collectively distinguished early AHI patients from non-
infected controls. The activity of transcriptional modules
related to interferon, cell cycle, cytotoxic, and mitochon-
drial responses were significantly increased in AHI
patients. At study enrollment, the intensity of this signa-
ture was not correlated with viral load and exhibited het-
erogeneity between patients. Association between viral
load and signature intensity was found over time. How-
ever, three patients exhibited little change in transcrip-
tional activity despite high viral loads. When compared to
acute RSV and Influenza infections, only interferon signa-
tures were conserved across all three infections while cell
cycle, cytotoxic, and mitochondrial responses were
unique to AHI. The AHI signature of untreated patients
regressed to non-infected control levels by 12–24 weeks
post enrollment. The initiation of ART accelerated the dis-
sipation of this signature, returning the core AHI signature
to normal levels within 4 weeks.
Conclusion
The whole blood AHI transcriptional signature is unique,
transient, and capable of classifying individual responses
to infection. This signature is responsive to ART and con-
tains pathways with both defined and novel associations
with HIV infection.
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